Search

Search Results

1. Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma

   Objective

   The incidence of non-virus-related hepatocellular carcinoma (NV-HCC) in hepatocellular carcinoma (HCC) is steadily increasing. The aim of...

   Yu Jiang, Shulin Chen, ... Ning Xue in Cancer Cell International

   Article Open access 02 October 2022
   

2. Implication of extrinsic and intrinsic apoptotic pathways in the targeted therapy of hepatocellular carcinoma using aptamer-labeled viramidine nanoparticles

   Hepatocellular carcinoma (HCC) is a global health problem with regional differences in epidemiological statistics. Co-assembling the drug...

   Ahmed A. Abd-Rabou, Hanaa H. Ahmed, Mohamed S. Kishta in BMC Cancer

   Article Open access 29 October 2022
   

3. Development of Purinergic Receptor Agonists and Antagonists

   Adenosine, P2Y, and P2X receptors have been the focus of purinergic ligand development in the pharmaceutical sector and academic medicinal chemistry...

   Kenneth A. Jacobson in Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration

   Chapter 2023
   

4. Advancing therapeutic efficacy: nanovesicular delivery systems for medicinal plant-based therapeutics

   The utilization of medicinal plant extracts in therapeutics has been hindered by various challenges, including poor bioavailability and stability...

   Mohamed J. Saadh, Mohammed Ahmed Mustafa, ... Laith H. Alzubaidi in Naunyn-Schmiedeberg's Archives of Pharmacology

   Article 03 May 2024
   

5. In Vitro Effects of Lithium Carbonate on Cell Cycle, Apoptosis, and Autophagy in Hepatocellular Carcinoma-29 Cells

   We studied the effects of lithium carbonate on the cell cycle, apoptosis, and autophagy in hepatocellular carcinoma-29 cells (HCC-29) in vitro . Flow...

   Y. S. Taskaeva, N. P. Bgatova, ... Z. B. Tungushbaeva in Bulletin of Experimental Biology and Medicine

   Article 02 December 2020

6. mTOR Signaling Pathways

   Jianling **e, Christopher G. Proud in Encyclopedia of Molecular Pharmacology

   Reference work entry 2021
   

7. mTOR Signaling Pathways

   Jianling **e, Christopher G. Proud in Encyclopedia of Molecular Pharmacology

   Living reference work entry 2021
   

8. Morphological Analysis of Blood Capillaries and Transport Function of Endothelial Cells in Hepatocellular Carcinoma-29

   Hepatocellular carcinoma is characterized by the pronounced vascularization, high levels of vascular endothelial growth factors, and intensive...

   Yu. S. Taskaeva, V. V. Makarova, ... N. P. Bgatova in Bulletin of Experimental Biology and Medicine

   Article 01 June 2020

9. Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

   Background

   All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that...

   Mineko Terao, Laura Goracci, ... Enrico Garattini in Journal of Experimental & Clinical Cancer Research

   Article Open access 29 October 2019
   

10. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

    Background

    Immunotherapy represents a promising option for treatment of hepatocellular carcinoma (HCC) in cirrhotic patients but its efficacy is...

    Ligia Craciun, Roland de Wind, ... Vincent Donckier in BMC Cancer

    Article Open access 19 February 2020
    

11. Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion

    Background

    Hepatitis D virus (HDV) infection may induce fulminant hepatitis in chronic hepatitis B patients (CHB) or rapid progression of CHB to...

    Yuh-** Liang, Cheng-Pu Sun, ... Jaw-Ching Wu in Journal of Biomedical Science

    Article Open access 21 May 2020
    

12. Cytological Characteristics of a Heterogeneous Population of Hepatocellular Carcinoma-29 Cells after Injection of Lithium Carbonate in the Experiment

    Five cytological types of hepatocellular carcinoma-29 (G-29) grown in the muscle tissue of the thigh of experimental animals were identified by...

    Yu. S. Taskaeva, N. P. Bgatova in Bulletin of Experimental Biology and Medicine

    Article 26 October 2019

13. Exosomal miRNAs in tumor microenvironment

    Tumor microenvironment (TME) is the internal environment in which tumor cells survive, consisting of tumor cells, fibroblasts, endothelial cells, and...

    Shiming Tan, Longzheng **a, ... Qian** Liao in Journal of Experimental & Clinical Cancer Research

    Article Open access 16 April 2020
    

14. Hepatitis C Virus Infection Caused by Infrequent Exposure in China Should Be of Concern

    **n-Cheng Qin, Li-Hua Zhong, ... Yong-Zhen Zhang in Virologica Sinica

    Article 21 February 2020
    

15. Ultrastructural Changes in Hepatocellular Carcinoma-29 Cells after Treatment with Lithium Carbonate

    We studied the effect of lithium carbonate on hepatocellular carcinoma-29 cells in CBA male mice after injection in a dose of 20 mM along the tumor...

    Yu. S. Taskaeva, N. P. Bgatova in Bulletin of Experimental Biology and Medicine

    Article 15 May 2019

16. Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?

    The human endogenous retroviruses HERV-K HML-2 have been considered a possible cause of human breast cancer (BrC). A HERV-K HML-2 fully intact...

    Mark H. Kaplan, Rafael Contreras-Galindo, ... Clement Adebamowo in Infectious Agents and Cancer

    Article Open access 07 March 2020
    

17. Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment

    Glycogen storage disorder type III (GSDIII), or debranching enzyme (GDE) deficiency, is a rare metabolic disorder characterized by variable liver,...

    Pascal Laforêt, Michio Inoue, ... Edoardo Malfatti in Acta Neuropathologica Communications

    Article Open access 28 October 2019
    

18. Causes of Congenital Malformations

    Congenital malformations are structural abnormalities due to faulty development, present at birth, and amongst the major causes of prenatal,...

    Martin Lammens, Mireille Bekker, ... Hans J. ten Donkelaar in Clinical Neuroembryology

    Chapter 2023
    

19. Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999–2009

    Purpose

    To evaluate liver cancer incidence rates and risk factor correlations in non-Hispanic AI/AN populations for the years 1999–2009.

    ...

    Stephanie C. Melkonian, Melissa A. Jim, ... Mary C. White in Cancer Causes & Control

    Article 20 July 2018
    

20. Abstracts from the 6th international conference on prevention & infection control (ICPIC 2021)

    in Antimicrobial Resistance & Infection Control

    Article Open access 03 September 2021